Kanagawa, Japan

Masaki Tsushima


Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 31(Granted Patents)


Location History:

  • Yokohama, JP (1995 - 1997)
  • Kanagawa-ken, JP (1997)
  • Kanagawa, JP (1995 - 2005)

Company Filing History:


Years Active: 1995-2005

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Masaki Tsushima

Introduction

Masaki Tsushima is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target opioid receptors. With a total of seven patents to his name, Tsushima's work has the potential to impact the treatment of various nerve system diseases.

Latest Patents

Among his latest patents, Tsushima has developed phenoxyalkylamine derivatives that serve as opioid δ receptor agonists. This medicament is designed for the preventive and therapeutic treatment of nerve system diseases. The active ingredient is represented by a specific general formula, which includes various substituents that enhance its pharmacological properties. Additionally, he has worked on diphenylalkylamine derivatives that are also useful as opioid receptor agonists, showcasing his focus on innovative therapeutic solutions.

Career Highlights

Throughout his career, Masaki Tsushima has been associated with prominent companies such as Meiji Seika Kaisha, Ltd. and Meiji Seika Kabushiki Kaisha. His work in these organizations has allowed him to advance his research and contribute to the development of new medicinal compounds.

Collaborations

Tsushima has collaborated with notable colleagues, including Katsuyoshi Iwamatsu and Atsushi Tamura. These partnerships have likely enriched his research and led to innovative breakthroughs in his field.

Conclusion

Masaki Tsushima's contributions to medicinal chemistry and his innovative patents highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in the treatment of nerve system diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…